New digital twin technology that allows a University of Virginia-developed artificial pancreas system to adapt to users’ changing needs – and lets users adjust the settings – has been shown to improve ...

Researchers at McGill University and the Research Institute of the McGill University Health Center (RI-MUHC) have developed a ...

An artificial pancreas has long been considered the holy grail for people with Type 1 diabetes, and new research suggests a more convenient version of this technology may help the millions of people ...

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review ...

A Canadian research team is examining the use of pramlintide in conjunction with insulin on the artificial-pancreas platform, with the goal of further improving blood glucose management for type 1 ...

When used in an appropriately trained and equipped clinic setting, supported open-source artificial pancreas systems (SOSAPS) are at least as safe and effective as retail APS, but with lower cost. An ...

Researchers design a novel algorithm for controlling implanted insulin pumps that accounts for the unique characteristics of individual patients. Their model, tested using an FDA-approved diabetes ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The CamAPS FX links compatible CGMs and insulin pumps ...

An artificial pancreas improves blood sugar control in children ages 2 to 6 with type 1 diabetes, according to a new study. An artificial pancreas originally developed at the University of Virginia ...

Cambridge scientists have successfully trialled an artificial pancreas for use by patients living with type 2 diabetes. The device – powered by an algorithm developed at the University of Cambridge – ...

Please provide your email address to receive an email when new articles are posted on . The FDA has authorized CamAPS FX, a closed loop algorithm that links compatible continuous glucose monitors and ...